This conclusion differs from a recent report that describes a haploinsufficient heterozygous mutation in GLI3 in a subpopulation of congenital mastocytosis with Greig cephalopolysyndactyly syndrome and implicates the canonical HH-pathway in aggressive mastocytosis and cultured neoplastic mast cells (16). The gene discussed is GLI3; the disease is mastocytosis.